期刊文献+

慢性肺疾病患儿外周血17个免疫细胞因子的研究 被引量:4

Study of 17 immune cytokines in the peripheral blood of premature infants with chronic lung disease
暂未订购
导出
摘要 目的通过研究早产儿慢性肺疾病外周血17个细胞因子的改变,探讨早产儿慢性肺疾病的部分免疫发病机制。方法将26例住院满28d的早产儿分为慢性肺疾病组(14例)和对照组(12例),用multi-plex技术检测外周血中17个细胞因子(IL-1b,IL-2,IL-4,IL-5,IL-6,IL-7,IL-8,IL-10,IL-12,IL-13,IL-17,GM-CSF,IFN-γ,TNF-α,G-CSF,MCP-1,MIP-1b)的表达水平。结果慢性肺疾病组外周血中的17个细胞因子与对照组相比均无统计学差异(P>0.05)。结论早产儿慢性肺疾病发病后期的发病机制主要不是免疫因素造成的。 Objective To explore the immunomechanism of chronic lung disease(CLD) in prema-ture infants by investigating the changes of 17 cytokines.Methods Twenty-six preterm neonates who had been in the NICU for over 28 days were divided into CLD group(n=14) and control group consisting of 12 preterm neonates.Seventeen cytokines,namely interleukin 1b(IL-1b),IL-2,IL-4,IL-5,IL-6,IL-7,IL-8,IL-10,IL-12,IL-13,IL-17,granulocyte-macrophage col-ony-stimalating factor,interferon-γ,tumour necrosis factor alpha,granulocyte colony-stimulating factor,monocyte chemoattractant protein 1,and macrophage inflammatory protein-1b were de-tected in a single sample of peripheral blood by multi-plex technology(Bio-plex).Results There were no significant differences in the level of the 17 cytokines between the two groups(P〉0.05).Conclusion The cytokines examined may not be involved in the later period pathogenesis of CLD.
作者 罗英 黄为民
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第2期331-333,共3页 Journal of Southern Medical University
基金 广东省自然科学基金(7005170)
关键词 细胞因子 慢性肺疾病 早产儿 cytokines chronic lung disease preterm neonates
  • 相关文献

参考文献12

  • 1封志纯,李秋平.早产儿慢性肺部疾病诊治进展[J].实用儿科临床杂志,2007,22(2):81-83. 被引量:20
  • 2Bose CL, Laughon MM, Dammann CE. Bronchopulmonary dysplasia and inflammatory bio-markers in the premature neonate [J]. Arch Dis Child Fetal Neonatal Ed, 2008, 93(6): F455-61.
  • 3Kunzmann S, Speer CP, Jobe AH, et al. Motion induced TGF-betal but suppressed CTGF an-tenatal inflammation-in preterm lungs [J ]. Am J Physiol Lung Cell Mol Physiol, 2007, 292:L223-31.
  • 4Truog WE, Ballard PL, Norberg M, et al. Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide [ J ]. Pediatrics, 2007, 119: 670-8.
  • 5De Dooy J, Ieven M, Stevens W, et al. High levels of CXCL8 in tracheal aspirate samples taken at birth are associated with adverse respiratory outcome only in preterm infants younger than 28 weeks gestation[J]. Pediatr Pulmonol, 2007, 42: 193-203.
  • 6Mahieu LM, De Dooy JJ, Ieven MM, et al. Increased levels of tumor necrosis factor-alpha and decreased levels of interleukin-12 p 70 in tracheal aspirates, within 2 hrs after birth, are associated with mortality among ventilated preterm infants [I]. Pediatr Crit Cara Med, 2005, 6: 682-9.
  • 7Jonsson B, Li YH, Noack G, et al. Downregulatory cytokines in tmcheobronchial aspirate fluid from infants with chronic lung disease ofprematurity[J]. Acta Paediatr, 2000, 89(11): 1375-80.
  • 8Beresford MW, Shaw NJ. Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome[J]. Pediatr Res, 2002, 52: 973-8.
  • 9Baier RJ, Majid A, Parupia H, et al. CC chemokine concentrations increase in respiratory dis-tress syndrome and correlate with development of bronchopulmonary dysplasia [ J ]. Pediatr Pulmonol, 2004, 37: 137-48.
  • 10Capoluongo E, Vento G, Santonocito C, et al. Comparison of serum levels of seven cytokines in premature newborns undergoing different ventilatory procedures: high frequency oscillatory ventilation or synchronized intermittent mandatory ventilation [J ]. Eur Cytokine Netw, 2005, 16(3): 199-205.

二级参考文献15

  • 1Land RD.Neonatal chronic lung disease in the post-surfactant era[J].Biol Neonate,2005,88(3):181-191.
  • 2Stevenson DK,Wright LL,Lemons JA,et al.Very low birth weight outcomes of the national institute of child health and human development neonatal research network,january 1993 through december 1994[J].Am J Obstet Gynecol,1998,179:1632-1639.
  • 3Nprtjwau W Jr,Rosan R,Porter D.Pulmonary disease following respirator therapy of hyaline-membrane disease:Bronchopulmonary dysplasia[J].N Engl J Med,1967,276:357-368.
  • 4Bancalari E,Abdenour GE,Feller R,et al.Bronchopulmonary dyspla-sia:Clinical presentation[J].J Pediatr,1979,95:819-823.
  • 5American Thoracic Society.Statement on the care of the child with chronic lung disease of infancy and childhood[J].Am J Respir Crit Care Med,2003,168:356-396.
  • 6Kotecha S,Allen J.Oxygen therapy for infants with chronic lung disease[J].Arch Dis Child Fetal Neonatal Ed,2002,87(3):234.
  • 7Mabanta CG,Pryhuber GS,Weinberg GA,et al.Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for,or colonized or infected with ureaplasma urealyticum[J].Paediatr Drugs,2003,5(7):463-480.
  • 8Coalson JJ.Pathology of chronic lung disease of early infancy.In:Bland RD,Coalson JJ.Chronic lung disease in early infancy[M].New York:Marcel Dekker,2000:85-124.
  • 9Couser RJ,Ferrara TB,Wright GB.Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room[J].J Pediatr,1996,128:631-637.
  • 10Coalson JJ,King RJ,Yang F.SP-A deficiency in primate model of bronchopulmonary dysplasia with infection:In situ mRNA and immunostains[J].Am J Respir Crit Care Med,1995,151:854-866.

共引文献19

同被引文献65

引证文献4

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部